FORDYCE MARSHALL (President and CEO) sold 8.5% of their position (18.50K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $701.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/24/2026ACC: 0001859453-26-000008
DirectorOfficer· President and CEO
Since May 2021
-18.50K
Net shares
Net seller
$701.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
18.50K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−18.41K
Price / share
$37.93
Trade value
$698.39K
% of position
8.5%
6/23/2026
216.74K→198.33K
Class A Common Stock
Direct
Shares
−88.00
Price / share
$38.43
Trade value
$3.38K
% of position
0.0%
6/23/2026
198.33K→198.24K
Total
Net shares
−18.50K
Net value
-$701.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/23/2026 | S · Sale | −18.41K | $37.93 | $698.39K | 8.5% | 216.74K | 198.33K |
| Class A Common Stock Direct | 6/23/2026 | S · Sale | −88.00 | $38.43 | $3.38K | 0.0% | 198.33K | 198.24K |
| Total | −18.50K | -$701.77K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned122.95K
Class A Common Stock
IndirectShares owned99.08K
Total
222.03K indirect222.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 122.95K | Indirect |
| Class A Common Stock | 99.08K | Indirect |
| Total | 222.03K | 222.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported